A Phase 4 Randomised, Double-Blind, Placebo-Controlled, Parallel-Group, Multi-Centre Study of Colesevelam as Add-on Therapy in Patients with Familial Hypercholesterolaemia

Mise à jour : Il y a 5 ans
Référence : EUCTR2007-000582-37

Femme et Homme

  • | Pays :
  • -
  • | Organes :
  • -
  • | Spécialités :
  • -

Extrait

1. Assess the efficacy of colesevelam added to a maximal tolerated and stable regimen of statin and ezetimibe in further decreasing the low-density lipoprotein (LDL) cholesterol level in terms of additional percentage decrease and in terms of reaching below target level of LDL cholesterol. 2. Evaluate the safety and tolerability of colesevelam added to a maximal tolerated and stable regimen of statin and ezetimibe.


Critère d'inclusion

  • Familial hypercholesterolaemia